Literature DB >> 22138891

Ten-year prospective follow-up of histological changes at five points on the gastric mucosa as recommended by the updated Sydney system after Helicobacter pylori eradication.

Masaaki Kodama1, Kazunari Murakami, Tadayoshi Okimoto, Ryugo Sato, Masahiro Uchida, Takashi Abe, Seiji Shiota, Yoshifumi Nakagawa, Kazuhiro Mizukami, Toshio Fujioka.   

Abstract

BACKGROUND: Atrophic gastritis and intestinal metaplasia (IM) are well known as precancerous lesions of gastric cancer. The present study evaluated the gastric mucosa for 10 years after H. pylori eradication at five points of the stomach as recommended by the updated Sydney system to clarify the relationship between H. pylori eradication and gastric cancer prevention.
METHODS: Among the comprised 373 patients, 323 were H. pylori-positive while 50 patients were H. pylori-negative. Patients with successful eradication underwent follow-up endoscopic examination every year. Biopsy specimens were taken from five points of the stomach, as recommended by the updated Sydney system, and were evaluated for the degree of gastritis prospectively.
RESULTS: Two hundred ninety-four out of the 323 H. pylori-positive patients successfully achieved eradication. Of the 197 patients on whom five-point biopsy was performed, the courses of 30 patients were able to be observed every year for 10 years after successful eradication. Inflammation, activity, and atrophy score at all five points were significantly reduced half a year to 6 years after eradication. IM scores fluctuated intensely up and down during all observation periods; however, IM score of the lesser curvature of the corpus continued decreasing gradually and showed a significant decrease 6 years after (0.97 ± 0.09 to 0.42 ± 0.17, P < 0.05).
CONCLUSION: In 10 years after H. pylori eradication, atrophy at all sites and IM in the lesser curvature of the corpus gradually and significantly decreased. These results suggest that the improvement of gastric atrophy and IM might have association with the reduction of gastric cancer occurrence.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22138891     DOI: 10.1007/s00535-011-0504-9

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  40 in total

1.  Helicobacter pylori but not high salt induces gastric intraepithelial neoplasia in B6129 mice.

Authors:  Arlin B Rogers; Nancy S Taylor; Mark T Whary; Erinn D Stefanich; Timothy C Wang; James G Fox
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

2.  High salt diets dose-dependently promote gastric chemical carcinogenesis in Helicobacter pylori-infected Mongolian gerbils associated with a shift in mucin production from glandular to surface mucous cells.

Authors:  Sosuke Kato; Tetsuya Tsukamoto; Tsutomu Mizoshita; Harunari Tanaka; Toshiko Kumagai; Hiroyoshi Ota; Tsutomu Katsuyama; Masahiro Asaka; Masae Tatematsu
Journal:  Int J Cancer       Date:  2006-10-01       Impact factor: 7.396

3.  Gastric MALT lymphomas are divided into three groups based on responsiveness to Helicobacter Pylori eradication and detection of API2-MALT1 fusion.

Authors:  Hiroshi Inagaki; Tsuneya Nakamura; Chunmei Li; Toshiro Sugiyama; Masahiro Asaka; Jyunichi Kodaira; Masahiro Iwano; Tsutomu Chiba; Kazuichi Okazaki; Atsunaga Kato; Ryuzo Ueda; Tadaaki Eimoto; Shiro Okamoto; Naomi Sasaki; Naomi Uemura; Taiji Akamatsu; Hideharu Miyabayashi; Yoko Kawamura; Hidemi Goto; Yasumasa Niwa; Takio Yokoi; Masao Seto; Shigeo Nakamura
Journal:  Am J Surg Pathol       Date:  2004-12       Impact factor: 6.394

Review 4.  Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis.

Authors:  Alexander C Ford; Brendan C Delaney; David Forman; Paul Moayyedi
Journal:  Am J Gastroenterol       Date:  2004-09       Impact factor: 10.864

5.  Association between diversity in the Src homology 2 domain--containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer.

Authors:  Takeshi Azuma; Shiho Yamazaki; Akiyo Yamakawa; Masahiro Ohtani; Atsushi Muramatsu; Hiroyuki Suto; Yoshiyuki Ito; Manabu Dojo; Yukinao Yamazaki; Masaru Kuriyama; Yoshihide Keida; Hideaki Higashi; Masanori Hatakeyama
Journal:  J Infect Dis       Date:  2004-02-02       Impact factor: 5.226

6.  Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer?

Authors:  Lorenzo Fuccio; Rocco Maurizio Zagari; Leonardo Henry Eusebi; Liboria Laterza; Vincenzo Cennamo; Liza Ceroni; Diego Grilli; Franco Bazzoli
Journal:  Ann Intern Med       Date:  2009-07-21       Impact factor: 25.391

7.  Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels.

Authors:  Kimihiko Yanaoka; Masashi Oka; Hiroshi Ohata; Noriko Yoshimura; Hisanobu Deguchi; Chizu Mukoubayashi; Shotaro Enomoto; Izumi Inoue; Mikitaka Iguchi; Takao Maekita; Kazuki Ueda; Hirotoshi Utsunomiya; Hideyuki Tamai; Mitsuhiro Fujishiro; Masataka Iwane; Tatsuya Takeshita; Osamu Mohara; Masao Ichinose
Journal:  Int J Cancer       Date:  2009-12-01       Impact factor: 7.396

8.  Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.

Authors:  Benjamin Chun-Yu Wong; Shiu Kum Lam; Wai Man Wong; Jian Shun Chen; Ting Ting Zheng; Rui E Feng; Kam Chuen Lai; Wayne Hsing Cheng Hu; Siu Tsan Yuen; Suet Yi Leung; Daniel Yee Tak Fong; Joanna Ho; Chi Kong Ching; Jun Shi Chen
Journal:  JAMA       Date:  2004-01-14       Impact factor: 56.272

9.  Long-term follow-up of gastric histology after Helicobacter pylori eradication.

Authors:  G M Forbes; J R Warren; M E Glaser; D J Cullen; B J Marshall; B J Collins
Journal:  J Gastroenterol Hepatol       Date:  1996-07       Impact factor: 4.029

10.  Improvement in gastric histology following Helicobacter pylori eradication therapy in Japanese peptic ulcer patients.

Authors:  H Watanabe; N Yamaguchi; H Kuwayama; C Sekine; N Uemura; M Kaise; T Nakamura; M Kubo; S Yoshida; K Haruma; M Inoue; T Shimatani; E Sanuki; H Mieno; M Kawanishi; S Nakazawa; T Tanaka
Journal:  J Int Med Res       Date:  2003 Sep-Oct       Impact factor: 1.671

View more
  44 in total

1.  Chemoprevention of gastric cancer development after Helicobacter pylori eradication therapy in an East Asian population: Meta-analysis.

Authors:  Mitsushige Sugimoto; Masaki Murata; Yoshio Yamaoka
Journal:  World J Gastroenterol       Date:  2020-04-21       Impact factor: 5.742

2.  Long-term monitoring of gastric atrophy and intestinal metaplasia after Helicobacter pylori eradication.

Authors:  Kazunari Murakami; Masaaki Kodama; Yoshihumi Nakagawa; Kazuhiro Mizukami; Tadayoshi Okimoto; Toshio Fujioka
Journal:  Clin J Gastroenterol       Date:  2012-06-17

3.  Methylation-dependent activation of CDX1 through NF-κB: a link from inflammation to intestinal metaplasia in the human stomach.

Authors:  Tilman T Rau; Anja Rogler; Myrjam Frischauf; Andreas Jung; Peter C Konturek; Arno Dimmler; Gerhard Faller; Bettina Sehnert; Wael El-Rifai; Arndt Hartmann; Reinhard E Voll; Regine Schneider-Stock
Journal:  Am J Pathol       Date:  2012-06-27       Impact factor: 4.307

Review 4.  Gastric cancer development after the successful eradication of Helicobacter pylori.

Authors:  Kaname Uno; Katsunori Iijima; Tooru Shimosegawa
Journal:  World J Gastrointest Oncol       Date:  2016-03-15

Review 5.  Gastric cancer: prevention, screening and early diagnosis.

Authors:  Victor Pasechnikov; Sergej Chukov; Evgeny Fedorov; Ilze Kikuste; Marcis Leja
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

6.  Prevalence of Helicobacter pylori infection and atrophic gastritis in patients with dyspeptic symptoms in Myanmar.

Authors:  Thein Myint; Seiji Shiota; Ratha-korn Vilaichone; New Ni; Than Than Aye; Miyuki Matsuda; Trang Thi Huyen Tran; Tomohisa Uchida; Varocha Mahachai; Yoshio Yamaoka
Journal:  World J Gastroenterol       Date:  2015-01-14       Impact factor: 5.742

7.  Virulence genes of Helicobacter pylori in the Dominican Republic.

Authors:  Seiji Shiota; Modesto Cruz; José A Jiménez Abreu; Takahiro Mitsui; Hideo Terao; Mildre Disla; Shun Iwatani; Hiroyuki Nagashima; Miyuki Matsuda; Tomohisa Uchida; Lourdes Tronilo; Eduardo Rodríguez; Yoshio Yamaoka
Journal:  J Med Microbiol       Date:  2014-06-25       Impact factor: 2.472

Review 8.  Helicobacter pylori eradication for preventing gastric cancer.

Authors:  Bin Lu; Meng Li
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

Review 9.  Helicobacter pylori infection in Japan.

Authors:  Seiji Shiota; Kazunari Murakawi; Rumiko Suzuki; Toshio Fujioka; Yoshio Yamaoka
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2013-01       Impact factor: 3.869

Review 10.  Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development.

Authors:  Jiro Watari; Nancy Chen; Peter S Amenta; Hirokazu Fukui; Tadayuki Oshima; Toshihiko Tomita; Hiroto Miwa; Kheng-Jim Lim; Kiron M Das
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.